Acrivon Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $46k | 9.3k | 4.92 |
| 2023-09-30 | $91k | 9.5k | 9.56 |
| 2023-06-30 | $117k | 9.0k | 12.96 |